ABOUT DANAHER LIFE SCIENCES
Every day, scientists around the world are dedicated to unraveling the mysteries of disease, discovering novel therapies and vaccines, and conducting crucial drug testing. At Danaher Life Sciences, a collection of businesses within Danaher Corporation, we play a pivotal role in facilitating these cutting-edge scientific endeavors. Our comprehensive capabilities go beyond research, enabling us to drive the development of innovative biopharmaceuticals, revolutionary cell and gene therapies, and other breakthrough treatments that propel patient health forward and enhance treatment outcomes.


FEATURED ARTICLES
-
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
Explore how automated screening can accelerate CLD while preserving selection confidence, identifying promising candidates that manual methods may miss, and predicting poor fed-batch performers.
-
See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
-
Cell clumping can dramatically affect counting accuracy. Learn how declustering, mixing, and aspiration settings influence cell density measurements and help generate more reliable viability.
-
mRNA analysis depends on methods that can separate broad size ranges. Learn how retention time can help estimate transcript length and complement capillary electrophoresis workflows.
-
Aggregation can compromise mAb quality at many stages of development. Learn why size exclusion chromatography is a trusted approach for detecting aggregates and supporting confident characterization.
-
Peptide mapping helps reveal AAV capsid protein identity, sequence coverage, and potential modification patterns, giving gene therapy teams a clearer view of viral protein quality across workflows.
-
ADC characterization does not have to be overwhelmed by complex intact MS profiles. Smart column selection can improve separation, clarify critical quality attributes, and make ADC analysis easier.
-
Glycan profiling starts with effective clean-up. See how comparable recovery across key labeled glycans and sialylated glycan groups can support confident analysis while helping labs manage costs.
-
DAR is a key quality attribute that shapes ADC potency, safety, stability, and developability. Learn why accurate measurement and control are essential as ADC pipelines expand and expectations rise.
-
SEC for monoclonal antibodies is not always as simple as choosing a column and running PBS. Secondary interactions can affect recovery, making thoughtful method development essential.
-
Read about how HPLC protein purification enables precise, reproducible isolation of target proteins from complex mixtures while preserving structure and activity—supporting high-purity workflows.
-
Effective protein purification starts with matching the method to the molecule and the application. Learn how scale, throughput, purity goals, and empirical optimization influence successful recovery.
-
CRISPR is transforming medicine, but precision remains critical. Off-target effects pose ongoing safety challenges, driving the need for rigorous, multidimensional evaluation strategies.
-
Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.
-
Protein engineering is rapidly shifting toward faster, design-driven innovation. Discover how AI, advanced synthesis, and scalable workflows unlock new applications in drug development.
-
Learn how to design and execute mutagenesis experiments with practical guidance on primer design, PCR strategies, and troubleshooting that helps improve results and reduce trial-and-error in the lab.
-
Gain a clear understanding of CRISPR fundamentals, from molecular mechanisms to experimental design, as well as how to improve precision and reduce off-target effects for more reliable results.
-
Precise genome editing depends on improving HDR efficiency. Learn how guide selection, template design, homology arm optimization, and delivery strategies work together to drive higher-fidelity edits.
-
Synthetic biology is transforming antibody discovery. See how enabling faster screening, greater diversity, and more precise optimization of candidates improves performance and development success.
CONTACT INFORMATION
Danaher Life Sciences
500 Old Connecticut Path
Framingham, MA 01701
UNITED STATES